Publications by authors named "J M Campistol Plana"
Background: The burden and functional significance of autonomic dysfunction among survivors of childhood cancer is unknown.
Objectives: We evaluated the prevalence, risk factors, and functional relevance of autonomic dysfunction in survivors.
Methods: We conducted a cross-sectional prospective evaluation of 1,041 adult survivors of childhood cancer treated with anthracyclines (31.
Background And Objective: Recommendations of first-line therapies for metastatic hormone-sensitive (mHSPC), nonmetastatic castrate-resistant (M0CRPC), and metastatic castrate-resistant (mCRPC) prostate cancer do not account for cardiotoxicity due to a lack of clear prior evidence. This manuscript assesses cardiotoxicity of these therapies.
Methods: We searched Ovid Medline, Elsevier Embase, and the Cochrane Library for randomized clinical trials (RCTs) from database inception to January 14, 2024.
Article Synopsis
- * New techniques in cardiovascular imaging are crucial for detecting and managing heart risks in cancer patients, but there's still disagreement on the best approaches to using these imaging methods in different treatment settings.
- * This scientific statement aims to outline the current evidence for cardiovascular imaging in cancer care and to suggest new methods for its application, ultimately providing clearer guidance for integrating imaging into clinical practice.
Article Synopsis
- Hereditary transthyretin amyloidosis (hATTR/ATTRv) is caused by the buildup of misfolded transthyretin protein, affecting peripheral nerves, and inotersen has shown promise in treating the associated polyneuropathy, according to the NEURO-TTR study results.
- The study included patients from Europe and North America who participated in a long-term open-label extension study, focusing on various efficacy measures like the modified Neuropathy Impairment Score and quality of life assessments while also monitoring safety.
- Results indicated that a significant proportion of patients improved or maintained their neurological function over time, with 39 patients who initially received a placebo showing notable progress
Septic shock is a life-threatening host response to infection and a significant contributor to cost burden in the United States. Furthermore, sepsis-related inflammation has been linked to myocardial infarction (MI). We sought to examine the association of type 1 and type 2 MI with outcomes in hospitalizations admitted with septic shock.
View Article and Find Full Text PDF